Category: News Post
-
A Statement on Needed Reforms to Protect Patient Safety from Fred H. Mills Jr., PharmD – ASEM Chief Policy Officer
“As a compounding pharmacist for nearly 50 years, I know the importance of legitimate, patient-specific compounding. I also know that there is a fundamental difference between the compounding that ensures a cancer patient has the right treatment dosage versus the mass compounding of GLP-1s today – unvetted additives, no batch consistency, telehealth distribution by faux-pharmacists,…
-
Americans for Safe and Effective Medicines Launches
Americans for Safe and Effective Medicines (ASEM) today launched as a new national advocacy organization dedicated to protecting patients from illegal mass compounding, counterfeit products, and misleading marketing practices and holding bad actors accountable…
-
Why We Created ASEM — And Why Now
Most people have never heard of pharmaceutical compounding. But if you’ve been following the surge in GLP-1 weight-loss medications, you’ve almost certainly encountered it — whether you knew it or not. Real compounding has a legitimate place in medicine: a licensed pharmacist, working from a valid prescription, prepares a customized medication for one patient when…